Home

Eli Lilly (LLY)

713.71
-1.49 (-0.21%)
NYSE · Last Trade: May 24th, 7:30 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close715.20
Open710.00
Bid714.00
Ask714.79
Day's Range709.00 - 719.64
52 Week Range677.09 - 972.53
Volume2,642,511
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield6.000 (0.84%)
1 Month Average Volume4,821,362

Chart

About Eli Lilly (LLY)

Eli Lilly is a global pharmaceutical company dedicated to discovering, developing, manufacturing, and marketing innovative medicines that address some of the world's most challenging health issues. The company focuses on areas such as diabetes, oncology, immunology, and neurodegenerative diseases, providing a wide range of treatments designed to improve patient outcomes and quality of life. Eli Lilly is committed to scientific advancement and works collaboratively with healthcare professionals and researchers to bring new therapies and solutions to market, ensuring access to life-saving medications for patients around the globe. Read More

News & Press Releases

Value Investing Is Not Dead - It Just Got Smarterbenzinga.com
Via Benzinga · May 23, 2025
3 Trades Members of Congress Are Making Right Now
Knowing what Congressional leaders are buying can give investors insight into future legislation that could benefit these companies
Via MarketBeat · May 23, 2025
Investing for the Long Term: 1 Unstoppable Vanguard ETF to Buy and Hold Foreverfool.com
Via The Motley Fool · May 23, 2025
Huge News for Eli Lilly Stock Investors!fool.com
Via The Motley Fool · May 18, 2025
2 Growth Stocks to Own for Decades and 1 to Steer Clear Of
Growth is oxygen. But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID cycle.
Via StockStory · May 23, 2025
5 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · May 22, 2025
Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dullstocktwits.com
Truist noted on Thursday that the $200/month price point is "highly attractive compared to other price points in the market," including Hims & Hers' compounded Semaglutide, Wegovy, and Liraglutide subscription programs.
Via Stocktwits · May 22, 2025
Better Weight Loss Stock: Amgen or Viking Therapeutics?fool.com
Via The Motley Fool · May 22, 2025
Did Eli Lilly Just Say Checkmate to Novo Nordisk?fool.com
Via The Motley Fool · May 22, 2025
Is the Vanguard Dividend Appreciation ETF a Buy Now?fool.com
Via The Motley Fool · May 22, 2025
Wegovy, Zepbound Just Got Cheaper: Cigna Sets $200 Monthly Limit For Weight-Loss Drug Usersstocktwits.com
Cigna’s Evernorth has reached agreements with Eli Lilly and Novo Nordisk to reduce prices for GLP-1 weight-loss drugs Wegovy and Zepbound
Via Stocktwits · May 22, 2025
Eli Lilly Options Trading: A Deep Dive into Market Sentimentbenzinga.com
Via Benzinga · May 21, 2025
Best Healthcare Stocks: Eli Lilly vs. Novo Nordiskfool.com
Via The Motley Fool · May 21, 2025
Trump's $6 Trillion Investment Deals Face Reality Check: Only A Fraction May Reach The Real Economybenzinga.com
Despite $6 trillion in promised investments under Trump, Goldman Sachs estimates only $30B–$135B will meaningfully impact U.S. GDP.
Via Benzinga · May 20, 2025
Marjorie Taylor Greene Goes Shopping For Tesla, Netflix, UnitedHealth And More: 19 Stocks The Congresswoman Boughtbenzinga.com
Marjorie Taylor Greene disclosing buying 19 different stocks in a new filing. The buys come less than two weeks after the purchase of 50 different stocks.
Via Benzinga · May 20, 2025
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · May 20, 2025
Apple, Nvidia, GM: CEOs Are Talking About Being American-Made Againbenzinga.com
US companies are reshoring manufacturing operations & investing billions in the country, led by Apple & Nvidia for tech, J&J & Eli Lilly for healthcare, Anheuser-Busch for beer, & Cra-Z-Art for toys. Detroit & beyond are benefiting from this trend.
Via Benzinga · May 20, 2025
Great News for Eli Lilly Stock Investors!fool.com
Via The Motley Fool · May 20, 2025
Ireland: America’s Gateway to Europe – The $2 Trillion Investment Story
Ireland has emerged as the undisputed champion in attracting U.S. foreign direct investment, hosting an extraordinary €897 billion (over $1 trillion) in American capital. This massive investment flow has transformed the small island nation into America's premier European platform, with U.S. affiliate assets reaching approximately $2 trillion in 2021.
Via AB Newswire · May 19, 2025
The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giantsbenzinga.com
is it the end of the diabetes industry? Here's a small cap that could upend the business models of pharma giants...
Via Benzinga · May 19, 2025
23andMe Finds A Big Biotech Buyer In $256 Million Bankruptcy Auctioninvestors.com
The acquirer says it will continue 23andMe's consumer genome testing services. It acquired a number of programs, including the biobank.
Via Investor's Business Daily · May 19, 2025
The Nasdaq Just Soared 30% From Its 2025 Low: 3 Vanguard ETFs to Buy Nowfool.com
Via The Motley Fool · May 18, 2025
Why Is Eli Lilly Stock Crashing and Is It a Buying Opportunity?fool.com
Via The Motley Fool · May 18, 2025
Got $1,000 to Invest? Buy This Top Vanguard ETF and Never Look Back.fool.com
Via The Motley Fool · May 17, 2025
MarketBeat Week in Review – 05/12 - 05/16
Stocks had a strong week on a potential U.S.-China trade deal and cooler inflation data, but volatility may remain as investors shift focus to tax cuts
Via MarketBeat · May 17, 2025